Summary: A single high dose of psilocybin produces more than a transient psychedelic “trip.” New research shows it increases brain entropy and leads to measurable anatomical and functional changes that can last at least one month. These changes predict next-day psychological insight and longer-term improvements in well-being and cognitive flexibility.
Researchers at UC San Francisco and Imperial College London report that a single 25 mg dose of psilocybin—administered to healthy volunteers who had never taken psychedelics—caused an immediate spike in neural signal diversity and, one month later, detectable strengthening of neural tracts. The study links these neural changes to increased psychological insight and lasting gains in mental health measures.
Key Facts
- Entropy spike: Within 60 minutes of a 25 mg dose, EEG recordings showed a substantial rise in cortical signal entropy, indicating more diverse and less stereotyped patterns of neural activity.
- Predicting insight: The magnitude of that entropic increase predicted how much emotional self-awareness and psychological insight participants reported the following day.
- Anatomical integrity: Diffusion tensor imaging (DTI) performed one month later showed denser, more organized diffusion along prefrontal-subcortical tracts—changes consistent with increased structural integrity rather than the diffusion seen with aging.
- Breaking rigid patterns: Psilocybin appeared to loosen entrenched patterns of brain activity, enabling cognitive revision and measurable increases in cognitive flexibility after four weeks.
- The experience matters: The study suggests the subjective psychedelic experience—the “trip” and the insights it produces—is not merely a side effect but a necessary component of the drug’s therapeutic impact.
Source: UCSF
Published May 5 in Nature Communications, this placebo-controlled, within-subjects study used EEG, functional MRI (fMRI), and diffusion tensor imaging (DTI) to compare effects after a 1 mg dose (placebo) and a 25 mg dose of psilocybin in 28 psychedelic‑naive adults. The combination of acute recordings during the peak experience and follow-up imaging one month later allowed the team to link immediate neural dynamics with subsequent structural and psychological changes.
What the researchers measured
Participants first received 1 mg of psilocybin, which functioned as an active placebo, and underwent EEG monitoring. Over subsequent weeks researchers assessed psychological insight, well-being, and cognitive performance. One month later, the same participants received 25 mg of psilocybin. EEG data recorded during the acute phase showed markedly higher cortical entropy after the higher dose. Follow-up DTI and fMRI scans, plus behavioral testing, tracked changes that emerged over the month after dosing.
Findings and implications
EEG increases in signal entropy at one and two hours post‑dose predicted improved psychological well‑being one month later. The next-day ratings of insight mediated the relationship between acute entropy and longer-term well-being, suggesting the subjective experience plays a causal role. DTI revealed decreased axial diffusivity in bilateral prefrontal-subcortical tracts a month after the 25 mg session, indicating more organized water diffusion consistent with denser tract integrity. Network modularity measured with fMRI decreased numerically and correlated with well-being gains.
Behaviorally, most participants rated their high-dose session as one of the most extraordinary conscious experiences of their lives. They reported greater psychological insight after the 25 mg dose than after the 1 mg dose and showed increased well-being at two and four weeks. Cognitive flexibility improved at the one-month assessment.
Key Questions Answered:
A: Brain entropy refers to the diversity and unpredictability of neural signals. Higher entropy reflects a richer repertoire of brain states, which can help break repetitive, rigid patterns of thinking that underlie conditions like depression and anxiety—opening space for new perspectives and insight.
A: DTI measures the diffusion of water along white matter tracts. After a high dose of psilocybin, researchers observed changes consistent with more organized diffusion—interpreted as denser or more coherent tract structure. The exact cellular mechanisms remain under investigation.
A: In this study, long-term improvements in well-being were closely linked to the experience of psychological insight. If a dose is too low to induce the entropic brain state and subsequent insight, the lasting therapeutic benefits may be reduced.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- The full journal paper was reviewed.
- Additional context was added by staff.
About this neuroscience and psychedelics research news
Author: Levi Gadye
Source: UCSF
Contact: Levi Gadye – UCSF
Image: Credit to Neuroscience News
Original research: “Human brain changes after first psilocybin use” by T. Lyons et al., Nature Communications. DOI: 10.1038/s41467-026-71962-3
Abstract (condensed)
This exploratory, placebo‑controlled EEG and MRI study in 28 psychedelic‑naive volunteers detected anatomical and functional brain changes from one hour to one month after a single 25 mg dose of psilocybin. The study reports increases in cognitive flexibility, psychological insight, and well‑being at one month, alongside DTI changes in prefrontal‑subcortical tracts and transient increases in cortical signal entropy that predict later improvements.
Authors and funding
Senior author: Robin Carhart‑Harris, PhD. Other contributors include Manesh Girn, PhD, Hannes Kettner, Adam Gazzaley, MD, PhD, and colleagues from UCSF and Imperial College London. Funding came from philanthropic donations to the Centre for Psychedelic Research (Imperial College London), the Alex Mosley Charitable Trust, the Beckley Foundation, and philanthropic support to Neuroscape and related labs.